RecruitingNCT07574138

Function of Beta Cells in Early-onset Diabetes Mellitus

Comparison of Beta Cell Functional Changes in Patients With Early-onset Type 2 Diabetes Mellitus and Those With Typical Onset

Sponsor

University Medical Center Ho Chi Minh City (UMC)

Enrollment

296 participants

Start Date

Feb 24, 2025

Study Type

OBSERVATIONAL

Conditions

Type 2 Diabetes Mellitus (T2DM)Beta Cell Function

Summary

* Research objectives: Evaluate and compare the clinical and paraclinical characteristics, complications, as well as the changes in beta cell function and HbA1C levels between two patient groups over a one-year follow-up period. +Research design: This is a prospective cohort study, monitoring patients at 3, 6, 9, and 12 months. * Study Population and Sample Size: The study is planned to be conducted on 296 Vietnamese patients (accounting for a 20% dropout rate) who are being examined at the University of Medicine and Pharmacy Hospital in Ho Chi Minh City. * Key Evaluation Indicators: The function of beta cells and insulin resistance status are measured through the indices of HOMA-B, HOMA-IR, fasting C-peptide levels, and HbA1C levels. * Time and location: The study will be conducted from February 2025 to February 2028 at the Endocrinology Clinic, University Medical Center Ho Chi Minh City.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Monitor and observe the clinical progression and beta cell function for people with beta cell function and type 2 diabetes mellitus (t2dm). The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.